Wednesday, July 8, 2026

pharma · HIV-1 Infection · HIV-1 infection

Gilead Sciences

Gilead Sciences clinical programs — 1 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

333 Lakeside Drive, Foster City, CA 94404, US HQ
1987 Founded
14,602 Employees
TGA registrant Type
Company details
Status
Public
HQ
333 Lakeside Drive, Foster City, CA 94404, US
Founded
1987
Employees
14,602
Programs
30
Drugs
54
Patents
0
Intelligence · Clinical Programs

Gilead Sciences projects

1 ClinicalTrials.gov programs sponsored by Gilead Sciences.

Gilead Sciences has 1 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. Biktarvy 50 mg/200 mg/25 mg film-coated tablets

    Gilead Sciences Pty Limited

    HIV-1 infection

    approved small molecule active

    1 trial

Frequently asked questions

How many clinical projects does Gilead Sciences have?

1 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.